Global Neurotrophins Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
- BMR3871615
- 116 Pages
- June 2020
- Healthcare
In terms of production side, this report researches the Neurotrophins production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Neurotrophins by regions (countries) and by Application.
The global Neurotrophins market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Neurotrophins market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Neurotrophins markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Neurotrophins market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Neurotrophins market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Neurotrophins market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Neurotrophins market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Neurotrophins market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Neurotrophins market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Neurotrophins market by each application segment for the same period.
This report includes the following manufacturers:
Johnson＆Johnson
Lonza Groups
FibroGen
Scil Proteins GmbH
Merck Serono
Scil Proteins GmbH
PeproTech
GE Healthcare
Market Segment by Type
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Dehydroepiandrosterone Sulfate
Other
Market Segment by Application
Alzheimer'S Disease
Amyotrophic Lateral Sclerosis
Parkinson'S Disease
Other
Research Methodology
To compile the detailed study of the global Neurotrophins market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Neurotrophins market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Neurotrophins market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1.1 Research Scope
1.2 Top Neurotrophins Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Neurotrophins Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Nerve Growth Factor
1.3.3 Brain-Derived Neurotrophic Factor
1.3.4 Dehydroepiandrosterone Sulfate
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Neurotrophins Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Alzheimer'S Disease
1.4.3 Amyotrophic Lateral Sclerosis
1.4.4 Parkinson'S Disease
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Neurotrophins Revenue (2015-2026)
2.1.1 Global Neurotrophins Revenue (2015-2026)
2.1.2 Global Neurotrophins Sales (2015-2026)
2.2 Global Neurotrophins Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Neurotrophins Sales by Regions (2015-2020)
2.2.2 Global Neurotrophins Revenue by Regions (2015-2020)
2.3 Global Top Neurotrophins Regions (Countries) Ranking by Market Size
2.4 Neurotrophins Industry Trends
2.4.1 Neurotrophins Market Trends
2.4.2 Neurotrophins Market Drivers
2.4.3 Neurotrophins Market Challenges
2.4.4 Neurotrophins Market Restraints
2.4.5 Primary Interviews with Key Neurotrophins Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Neurotrophins Manufacturers by Sales (2015-2020)
3.1.1 Global Neurotrophins Sales by Manufacturers (2015-2020)
3.1.2 Global Neurotrophins Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Neurotrophins Sales in 2019
3.2 Global Top Manufacturers Neurotrophins by Revenue
3.2.1 Global Neurotrophins Revenue by Manufacturers (2015-2020)
3.2.2 Global Neurotrophins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neurotrophins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophins as of 2019)
3.4 Global Neurotrophins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Neurotrophins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Neurotrophins Market
3.7 Key Manufacturers Neurotrophins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Neurotrophins Historic Market Review by Type (2015-2020)
4.1.2 Global Neurotrophins Sales Market Share by Type (2015-2020)
4.1.3 Global Neurotrophins Revenue Market Share by Type (2015-2020)
4.1.4 Neurotrophins Price by Type (2015-2020)
4.1 Global Neurotrophins Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Neurotrophins Sales Forecast by Type (2021-2026)
4.2.3 Global Neurotrophins Revenue Forecast by Type (2021-2026)
4.2.4 Neurotrophins Price Forecast by Type (2021-2026)
5 Global Neurotrophins Market Size by Application
5.1 Global Neurotrophins Historic Market Review by Application (2015-2020)
5.1.2 Global Neurotrophins Sales Market Share by Application (2015-2020)
5.1.3 Global Neurotrophins Revenue Market Share by Application (2015-2020)
5.1.4 Neurotrophins Price by Application (2015-2020)
5.2 Global Neurotrophins Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Neurotrophins Sales Forecast by Application (2021-2026)
5.2.3 Global Neurotrophins Revenue Forecast by Application (2021-2026)
5.2.4 Neurotrophins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neurotrophins Breakdown Data by Company
6.2 North America Neurotrophins Breakdown Data by Type
6.3 North America Neurotrophins Breakdown Data by Application
6.4 North America Neurotrophins Breakdown Data by Countries
6.4.1 North America Neurotrophins Sales by Countries
6.4.2 North America Neurotrophins Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neurotrophins Breakdown Data by Company
7.2 Europe Neurotrophins Breakdown Data by Type
7.3 Europe Neurotrophins Breakdown Data by Application
7.4 Europe Neurotrophins Breakdown Data by Countries
7.4.1 Europe Neurotrophins Sales by Countries
7.4.2 Europe Neurotrophins Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurotrophins Breakdown Data by Company
8.2 Asia Pacific Neurotrophins Breakdown Data by Type
8.3 Asia Pacific Neurotrophins Breakdown Data by Application
8.4 Asia Pacific Neurotrophins Breakdown Data by Regions
8.4.1 Asia Pacific Neurotrophins Sales by Regions
8.4.2 Asia Pacific Neurotrophins Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Neurotrophins Breakdown Data by Company
9.2 Latin America Neurotrophins Breakdown Data by Type
9.3 Latin America Neurotrophins Breakdown Data by Application
9.4 Latin America Neurotrophins Breakdown Data by Countries
9.4.1 Latin America Neurotrophins Sales by Countries
9.4.2 Latin America Neurotrophins Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neurotrophins Breakdown Data by Type
10.2 Middle East and Africa Neurotrophins Breakdown Data by Application
10.3 Middle East and Africa Neurotrophins Breakdown Data by Countries
10.3.1 Middle East and Africa Neurotrophins Sales by Countries
10.3.2 Middle East and Africa Neurotrophins Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 UAE
11 Company Profiles
11.1 Johnson＆Johnson
11.1.1 Johnson＆Johnson Corporation Information
11.1.2 Johnson＆Johnson Business Overview
11.1.3 Johnson＆Johnson Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Johnson＆Johnson Neurotrophins Products and Services
11.1.5 Johnson＆Johnson SWOT Analysis
11.1.6 Johnson＆Johnson Recent Developments
11.2 Lonza Groups
11.2.1 Lonza Groups Corporation Information
11.2.2 Lonza Groups Business Overview
11.2.3 Lonza Groups Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Lonza Groups Neurotrophins Products and Services
11.2.5 Lonza Groups SWOT Analysis
11.2.6 Lonza Groups Recent Developments
11.3 FibroGen
11.3.1 FibroGen Corporation Information
11.3.2 FibroGen Business Overview
11.3.3 FibroGen Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 FibroGen Neurotrophins Products and Services
11.3.5 FibroGen SWOT Analysis
11.3.6 FibroGen Recent Developments
11.4 Scil Proteins GmbH
11.4.1 Scil Proteins GmbH Corporation Information
11.4.2 Scil Proteins GmbH Business Overview
11.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Scil Proteins GmbH Neurotrophins Products and Services
11.4.5 Scil Proteins GmbH SWOT Analysis
11.4.6 Scil Proteins GmbH Recent Developments
11.5 Merck Serono
11.5.1 Merck Serono Corporation Information
11.5.2 Merck Serono Business Overview
11.5.3 Merck Serono Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Merck Serono Neurotrophins Products and Services
11.5.5 Merck Serono SWOT Analysis
11.5.6 Merck Serono Recent Developments
11.6 Scil Proteins GmbH
11.6.1 Scil Proteins GmbH Corporation Information
11.6.2 Scil Proteins GmbH Business Overview
11.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Scil Proteins GmbH Neurotrophins Products and Services
11.6.5 Scil Proteins GmbH SWOT Analysis
11.6.6 Scil Proteins GmbH Recent Developments
11.7 PeproTech
11.7.1 PeproTech Corporation Information
11.7.2 PeproTech Business Overview
11.7.3 PeproTech Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 PeproTech Neurotrophins Products and Services
11.7.5 PeproTech SWOT Analysis
11.7.6 PeproTech Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Corporation Information
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Neurotrophins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 GE Healthcare Neurotrophins Products and Services
11.8.5 GE Healthcare SWOT Analysis
11.8.6 GE Healthcare Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Neurotrophins Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Neurotrophins Sales Channels
12.2.2 Neurotrophins Distributors
12.3 Neurotrophins Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Neurotrophins Sales Forecast (2021-2026)
13.1.1 Global Neurotrophins Sales Forecast by Regions (2021-2026)
13.1.2 Global Neurotrophins Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Neurotrophins Sales Forecast (2021-2026)
13.2.2 North America Neurotrophins Revenue Forecast (2021-2026)
13.2.3 North America Neurotrophins Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Neurotrophins Sales Forecast (2021-2026)
13.3.2 Europe Neurotrophins Revenue Forecast (2021-2026)
13.3.3 Europe Neurotrophins Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Neurotrophins Sales Forecast (2021-2026)
13.4.2 Asia Pacific Neurotrophins Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Neurotrophins Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Neurotrophins Sales Forecast (2021-2026)
13.5.2 Latin America Neurotrophins Revenue Forecast (2021-2026)
13.5.3 Latin America Neurotrophins Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Neurotrophins Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Neurotrophins Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Neurotrophins Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Neurotrophins Key Market Segments
Table 2. Ranking of Global Top Neurotrophins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neurotrophins Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Nerve Growth Factor
Table 5. Major Manufacturers of Brain-Derived Neurotrophic Factor
Table 6. Major Manufacturers of Dehydroepiandrosterone Sulfate
Table 7. Major Manufacturers of Other
Table 8. Global Neurotrophins Market Share by Application 2019-2025 (K Units)
Table 9. Global Neurotrophins Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 10. Global Neurotrophins Sales by Regions 2015-2020 (K Units)
Table 11. Global Neurotrophins Sales Market Share by Regions 2015-2020
Table 12. Global Neurotrophins Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Neurotrophins Revenue Market Share by Regions 2015-2020
Table 14. Top Neurotrophins Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Neurotrophins Key Drivers: Impact Analysis (2021-2026)
Table 17. Neurotrophins Key Challenges
Table 18. Main Points Interviewed from Key Neurotrophins Players: Views for Future
Table 19. Global Neurotrophins Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Neurotrophins Sales Share by Manufacturers (2015-2020)
Table 21. Neurotrophins Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Neurotrophins Revenue Share by Manufacturers (2015-2020)
Table 23. Global Neurotrophins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophins as of 2019)
Table 25. Key Manufacturers Neurotrophins Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 26. Key Manufacturers Neurotrophins Plants/Factories Distribution
Table 27. Key Manufacturers Neurotrophins Area Served
Table 28. Date of Key Manufacturers Enter into Neurotrophins Market
Table 29. Key Manufacturers Neurotrophins Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Nerve Growth Factor Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 32. Global Brain-Derived Neurotrophic Factor Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 33. Global Dehydroepiandrosterone Sulfate Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 34. Global Other Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 35. Global Neurotrophins Sales (K Units) by Type (2015-2020)
Table 36. Global Neurotrophins Sales Share by Type (2015-2020)
Table 37. Global Neurotrophins Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Neurotrophins Price (K Units) by Type (2015-2020)
Table 39. Global Neurotrophins Sales (K Units) by Type (2021-2026)
Table 40. Global Neurotrophins Sales Share by Type (2021-2026)
Table 41. Global Neurotrophins Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Neurotrophins Revenue Share by Type (2021-2026)
Table 43. Global Neurotrophins Price (K Units) by Type (2021-2026)
Table 44. Global Neurotrophins Sales (K Units) by Application (2015-2020)
Table 45. Global Neurotrophins Sales Share by Application (2015-2020)
Table 46. Global Neurotrophins Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Neurotrophins Price by Application 2015-2020 (US$/Unit)
Table 48. Global Neurotrophins Sales by Application (2015-2020) (K Units)
Table 49. Global Neurotrophins Sales Share by Application (2015-2020)
Table 50. Global Neurotrophins Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Neurotrophins Revenue Share by Application (2021-2026)
Table 52. Global Neurotrophins Price (K Units) by Application (2021-2026)
Table 53. North America Neurotrophins Sales by Company (2015-2020) (K Units)
Table 54. North America Neurotrophins Sales Market Share by Company (2015-2020)
Table 55. North America Neurotrophins Sales by Type (2015-2020) (K Units)
Table 56. North America Neurotrophins Sales Market Share by Type (2015-2020)
Table 57. North America Neurotrophins Sales by Application (2015-2020) (K Units)
Table 58. North America Neurotrophins Sales Market Share by Application (2015-2020)
Table 59. North America Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 60. North America Neurotrophins Sales Market Share by Countries (2015-2020)
Table 61. North America Neurotrophins Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 63. Europe Neurotrophins Sales by Company (2015-2020) (K Units)
Table 64. Europe Neurotrophins Sales Market Share by Company (2015-2020)
Table 65. Europe Neurotrophins Sales by Type (2015-2020) (K Units)
Table 66. Europe Neurotrophins Sales Market Share by Type (2015-2020)
Table 67. Europe Neurotrophins Sales by Application (2015-2020) (K Units)
Table 68. Europe Neurotrophins Sales Market Share by Application (2015-2020)
Table 69. Europe Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 70. Europe Neurotrophins Sales Market Share by Countries (2015-2020)
Table 71. Europe Neurotrophins Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Neurotrophins Sales by Regions (2015-2020) (K Units)
Table 74. Asia Pacific Neurotrophins Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Neurotrophins Sales by Type (2015-2020) (K Units)
Table 76. Asia Pacific Neurotrophins Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Neurotrophins Sales by Application (2015-2020) (K Units)
Table 78. Asia Pacific Neurotrophins Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 80. Asia Pacific Neurotrophins Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Neurotrophins Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Neurotrophins Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Neurotrophins Sales by Company (2015-2020) (K Units)
Table 84. Latin America Neurotrophins Sales Market Share by Company (2015-2020)
Table 85. Latin America Neurotrophins Sales by Type (2015-2020) (K Units)
Table 86. Latin America Neurotrophins Sales Market Share by Type (2015-2020)
Table 87. Latin America Neurotrophins Sales by Application (2015-2020) (K Units)
Table 88. Latin America Neurotrophins Sales Market Share by Application (2015-2020)
Table 89. Latin America Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 90. Latin America Neurotrophins Sales Market Share by Countries (2015-2020)
Table 91. Latin America Neurotrophins Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Neurotrophins Sales by Type (2015-2020) (K Units)
Table 94. Middle East and Africa Neurotrophins Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Neurotrophins Sales by Application (2015-2020) (K Units)
Table 96. Middle East and Africa Neurotrophins Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 98. Middle East and Africa Neurotrophins Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Neurotrophins Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 101. Johnson＆Johnson Company Details
Table 102. Johnson＆Johnson Description and Business Overview
Table 103. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 104. Johnson＆Johnson Neurotrophins Sales Growth Rate (2015-2020)
Table 105. Johnson＆Johnson Neurotrophins Sales Market Share in Global Market
Table 106. Johnson＆Johnson Recent Development
Table 107. Lonza Groups Company Details
Table 108. Lonza Groups Description and Business Overview
Table 109. Lonza Groups Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 110. Lonza Groups Neurotrophins Sales Growth Rate (2015-2020)
Table 111. Lonza Groups Neurotrophins Sales Market Share in Global Market
Table 112. Lonza Groups Recent Development
Table 113. FibroGen Company Details
Table 114. FibroGen Description and Business Overview
Table 115. FibroGen Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 116. FibroGen Neurotrophins Sales Growth Rate (2015-2020)
Table 117. FibroGen Neurotrophins Sales Market Share in Global Market
Table 118. FibroGen Recent Development
Table 119. Scil Proteins GmbH Company Details
Table 120. Scil Proteins GmbH Description and Business Overview
Table 121. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 122. Scil Proteins GmbH Neurotrophins Sales Growth Rate (2015-2020)
Table 123. Scil Proteins GmbH Neurotrophins Sales Market Share in Global Market
Table 124. Scil Proteins GmbH Recent Development
Table 125. Merck Serono Company Details
Table 126. Merck Serono Description and Business Overview
Table 127. Merck Serono Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 128. Merck Serono Neurotrophins Sales Growth Rate (2015-2020)
Table 129. Merck Serono Neurotrophins Sales Market Share in Global Market
Table 130. Merck Serono Recent Development
Table 131. Scil Proteins GmbH Company Details
Table 132. Scil Proteins GmbH Description and Business Overview
Table 133. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 134. Scil Proteins GmbH Neurotrophins Sales Growth Rate (2015-2020)
Table 135. Scil Proteins GmbH Neurotrophins Sales Market Share in Global Market
Table 136. Scil Proteins GmbH Recent Development
Table 137. PeproTech Company Details
Table 138. PeproTech Description and Business Overview
Table 139. PeproTech Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 140. PeproTech Neurotrophins Sales Growth Rate (2015-2020)
Table 141. PeproTech Neurotrophins Sales Market Share in Global Market
Table 142. PeproTech Recent Development
Table 143. GE Healthcare Company Details
Table 144. GE Healthcare Description and Business Overview
Table 145. GE Healthcare Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 146. GE Healthcare Neurotrophins Sales Growth Rate (2015-2020)
Table 147. GE Healthcare Neurotrophins Sales Market Share in Global Market
Table 148. GE Healthcare Recent Development
Table 149. Neurotrophins Distributors List
Table 150. Neurotrophins Customers List
Table 151. Global Neurotrophins Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 152. Global Neurotrophins Sales Forecast by Type 2021-2026 (K Units)
Table 153. Global Neurotrophins Sales Forecast by Application 2021-2026 (K Units)
Table 154. Global Neurotrophins Sales Forecast by Regions 2021-2026 (K Units)
Table 155. Global Neurotrophins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 156. North America Neurotrophins Sales Forecast by Countries 2021-2026 (K Units)
Table 157. North America Neurotrophins Revenue Forecast by Countries 2021-2026
Table 158. Europe Neurotrophins Sales Forecast by Countries 2021-2026 (K Units)
Table 159. Europe Neurotrophins Revenue Market Share Forecast by Countries 2021-2026
Table 160. Asia Pacific Neurotrophins Sales Forecast by Regions 2021-2026 (K Units)
Table 161. Asia Pacific Neurotrophins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 162. Latin America Neurotrophins Sales Forecast by Countries 2021-2026 (K Units)
Table 163. Latin America Neurotrophins Revenue Forecast by Countries 2021-2026 (Million US$)
Table 164. Middle East and Africa Neurotrophins Sales Forecast by Regions 2021-2026 (K Units)
Table 165. Middle East and Africa Neurotrophins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurotrophins Product Picture
Figure 2. Global Neurotrophins Sales Market Shar by Type 2015-2026
Figure 3. Nerve Growth Factor Figures
Figure 4. Brain-Derived Neurotrophic Factor Figures
Figure 5. Dehydroepiandrosterone Sulfate Figures
Figure 6. Other Figures
Figure 7. Global Neurotrophins Sales Market Share by Application in 2019 & 2026
Figure 8. Alzheimer'S Disease Use Case
Figure 9. Amyotrophic Lateral Sclerosis Use Case
Figure 10. Parkinson'S Disease Use Case
Figure 11. Other Use Case
Figure 12. Neurotrophins Report Years Considered
Figure 13. Global Neurotrophins Market Size 2015-2026 (Million US$)
Figure 14. Global Neurotrophins Sales 2015-2020 (K Units)
Figure 15. Global Neurotrophins Market Size Market Share by Regions 2015-2020
Figure 16. Global Neurotrophins Sales Market Share by Regions in 2019
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Neurotrophins Sales Share by Manufacturers in 2019
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurotrophins Sales in 2019
Figure 20. Neurotrophins Value Share by Manufacturers in 2019
Figure 21. Neurotrophins Revenue Share by Manufacturers In 2019
Figure 22. Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Neurotrophins Revenue Share by Type (2015-2020)
Figure 24. Global Neurotrophins Revenue Growth Rate by Type in 2015 & 2019
Figure 25. Global Neurotrophins Market Share by Price Range (2015-2020)
Figure 26. Global Neurotrophins Revenue Share by Application (2015-2020)
Figure 27. Global Neurotrophins Revenue Growth Rate by Application in 2015 & 2019
Figure 28. North America Neurotrophins Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. U.S. Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 30. Canada Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 31. Europe Neurotrophins Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. Germany Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 37. Asia Pacific Neurotrophins Revenue Growth Rate 2015-2020 (Million US$)
Figure 38. China Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 39. Japan Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 40. South Korea Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 41. India Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 42. Australia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 43. Taiwan Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 44. Indonesia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 45. Thailand Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 46. Malaysia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 47. Philippines Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 48. Vietnam Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 49. Latin America Neurotrophins Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Mexico Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 51. Brazil Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 52. Argentina Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 53. Middle East and Africa Neurotrophins Revenue Growth Rate 2015-2020 (Million US$)
Figure 54. Turkey Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 55. Saudi Arabia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 56. UAE Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 57. Neurotrophins Value Chain
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. North America Neurotrophins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 61. North America Neurotrophins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Europe Neurotrophins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 63. Europe Neurotrophins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Asia Pacific Neurotrophins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. Asia Pacific Neurotrophins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Latin America Neurotrophins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Latin America Neurotrophins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Middle East and Africa Neurotrophins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Middle East and Africa Neurotrophins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
